Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga-68-PentixaFor PET/CT in Indolent B-cell Lymphoma
NCT06461182Phase 2Recruiting
- Sponsor
- Koo Foundation Sun Yat-Sen Cancer Center
- Start
- Apr 2024
- Primary completion
- Apr 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentixafor in B-cell non-Hodgkin lymphoma, sponsored by Koo Foundation Sun Yat-Sen Cancer Center. Started Apr 2024; status: recruiting.
02
Drugs
pentixafor
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT06461182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06461182.